Aspen Neuroscience, a clinical‑stage biotechnol
Author: Michael
Israel-based medtech targets easier, better-tole
Looking toward London 2026, new speakers broaden
NRG Therapeutics takes a first-in-human step tow
Phase 1b results for GT-02287 point to biologica
Studies of Brazilians living past 110 suggest re
Function launches new initiative that challenges
AstronauTx Ltd.
Amylyx Pharmaceuticals, Inc.
Omada Health said a 12‑month real‑world analy